Property:Has Dose
S
'''Acute'''; 500-750mg PO q12h x 3-7 days; Extend treatment x 1 week if immunocompromised; '''Chronic Carrier'''; 750mg PO q12h x 1 month +
T
''Not 1st line treatment''; 50-100mg/kg/day PO divided q6-8h x 14 days; First Dose: 12.5mg-33.3mg/kg PO x 1 +
''Not 1st line treatment''; 50-100mg/kg/day PO divided q6-8h x 14 days +
S
''Not 1st line treatment''; Acute; Immunocompetent; 500mg PO q8h x 3-7 days; Immunocompromised; 1000mg PO q8h x 3-14 days; Chronic carrier; 1000mg PO q8h x 3 months +
C
0.004 mg/kg IV bolus or 1 mg IV drip over 2 hours +
A
0.01 mg/kg (1:1000) SC or IM q20min x3 (max 0.5 mg) +
N
Newborn resuscitation#Epinephrine Persistent bradycardia despite ventilation and compressions Pediatric +
0.01-0.03mg/kg (0.1-0.3mL/kg of 1:10,000) IV/IO q3-5min +
V
0.01-0.5mcg/kg/min +
A
0.015 mg/kg IV or 1-2 mg IM; titrate 0.5-1.0 mg IV increments +
C
0.02 mg/kg IV (min 0.1 mg) +
R
0.02 mg/kg, no minimum dose +
O
0.02-0.05 mg/kg (min 0.1 mg) +
C
0.02-0.05 mg/kg IV (min 0.1 mg), double q5min +
N
0.02-0.05 mg/kg IV (min 0.1 mg), double q5min +
O
0.02-0.05 mg/kg IV (min 0.1 mg), double q5min +
E
0.02-0.05 mg/kg IV (min 0.1 mg), double q5min +
C
0.02-0.05mg/kg IV (min 0.1mg), double q5min until drying of secretions +
J
0.02mg/kg IV at rate no more than 0.5mg/min +
V
0.03 U/min (fixed dose), max 0.04 U/min +
S
0.03 units/min (fixed dose) +